The EAU Guidelines on Sexual and Reproductive Health aim to provide a comprehensive and evidence-based overview of the diagnosis and treatment relating to sexual and reproductive health in men. These Guidelines now cover the former EAU Guidelines on Male Sexual Dysfunction, Male Infertility and Male Hypogonadism.
In this webinar, Mr. Suks Minhas (GB) and Prof. Andreas Salonia (IT) will provide an overview of the new guidelines on two major topics, male hypogonadism and male infertility, which are of particular significance given the pandemic with SARS-CoV-2 and disproportionate mortality in men. They will summarise and provide evidence that both late onset hypogonadism and infertility are associated with significant cardiovascular disease and male cancers and are a proxy of overall men’s health.
In the webinar on male hypogonadism, Prof. Salonia will focus on some of the controversial aspects of these guidelines including the diagnosis and screening for hypogonadism, and the association of testosterone therapy with prostate cancer.
Mr. Minhas will focus on the controversies surrounding male infertility such as:
When to measure sperm DNA fragmentation
Expansion of the indications for the treatment of varicoceles
Managing the indeterminate lesion of the testis
Optimisation of the patient with non-obstructive azoospermia
- Publication date: June 2020
- Available languages: English
- Topic: Men’s Health
- CME: 1 European CME credit (ECMEC)
- Duration: Approx. 60 – 90 minutes